Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872688 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
Treatment of AS approximates natural life expectancy in select nonagenarians, with no significant difference in long-term survival between SAVR and TAVR. Importantly, patient quality of life improved at 1Â year. With appropriate selection, nonagenarians with severe AS can benefit from treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Molly Claire BA, Molly MD, Morley A. PhD, Siddique BS, Christina RN, Rebeca J. BA, Brandon A. BA, Katherine B. MD, Michael J. MD, Elizabeth M. MD, MPH,